EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MYCOPLASMA IST3 Results and Antimicrobial Susceptibility in PCR-Positive Urine Samples for Ureaplasma spp.

Rukiye Berkem iD, Tuğçe Özyol Atkaya iD

Antibiotics · 11.03.2026 · 15 (3) · 285

DOI: 10.3390/antibiotics15030285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 11.03.2026. Verfasst von Rukiye Berkem und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Ankara Training and Research Hospital, University of Health Sciences, Hacettepe Mh., Ulucanlar Cd., No: 89, Ankara 06230,…. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ureaplasma spp. and Mycoplasma hominis are urogenital pathogens that may be missed by routine culture, particularly in patients with genitourinary symptoms in whom conventional methods fail to identify an etiologic agent. Limited routine implementation of targeted diagnostics and antimicrobial susceptibility testing (AST) for these organisms may contribute to diagnostic uncertainty and treatment failure.

Methods

Seventy-five midstream urine samples submitted for suspected urinary tract infection and positive for Ureaplasma spp. according to a q-PCR urinary panel (Bioeksen, İstanbul, Türkiye) were tested the same day with MYCOPLASMA IST3 (bioMérieux, Marcy-l’Étoile, France) to assess growth and antimicrobial susceptibility. Results: q-PCR detected U. parvum in 54/75 (72%), U. urealyticum in 15/75 (20%), and both species in 6/75 (8%); M. hominis was not included in the PCR panel. MYCOPLASMA IST3 showed growth in 70/75 samples (positive percent agreement, 93.33%), while 5/75 (discordance, 6.66%) showed no growth. Among culture-positive samples, 57/70 (81.42%) yielded Ureaplasma spp. alone, and 13/70 (18.58%) yielded Ureaplasma spp. together with M. hominis. Resistance to levofloxacin and tetracycline was observed in 15.7% and 12.9% of Ureaplasma spp. isolates, respectively; resistance to moxifloxacin, erythromycin, and telithromycin was observed in 2.9% of isolates for each agent. In M. hominis isolates, no resistance to levofloxacin, moxifloxacin, or tetracycline was observed, whereas clindamycin resistance was observed in 7.7% of isolates.

Conclusions

In addition to intrinsic resistance, acquired antimicrobial resistance in Ureaplasma and Mycoplasma species appears to be increasing; therefore, treatment decisions should be guided by AST whenever feasible. Clinical laboratories should implement appropriate diagnostic methods for these organisms and perform susceptibility testing when indicated to support clinical decision making and optimize antimicrobial selection.

Schlagwörter

Stichwörter der Autor:innen

MYCOPLASMA IST3Mycoplasma hominisPCRUreaplasma parvumUreaplasma urealyticumantimicrobial resistanceantimicrobial susceptibility testingurinary tract infections

Autor:innen und Institutionen

  • Department of Microbiology, Ankara Training and Research Hospital, University of Health Sciences, Hacettepe Mh., Ulucanlar Cd., No: 89, Ankara 06230, Türkiye.

ORCID-Profile: Rukiye Berkem, Tuğçe Özyol Atkaya

Zitieren

APA

Berkem, R., & Özyol Atkaya, T. (2026). MYCOPLASMA IST3 Results and Antimicrobial Susceptibility in PCR-Positive Urine Samples for Ureaplasma spp. Antibiotics, 15(3), 285. https://doi.org/10.3390/antibiotics15030285

Vancouver

Berkem R, Özyol Atkaya T. MYCOPLASMA IST3 Results and Antimicrobial Susceptibility in PCR-Positive Urine Samples for Ureaplasma spp. Antibiotics. 2026;15(3):285. doi:10.3390/antibiotics15030285

BibTeX
@article{Berkem2026,
  author = {Berkem, Rukiye and Özyol Atkaya, Tuğçe},
  title = {MYCOPLASMA IST3 Results and Antimicrobial Susceptibility in PCR-Positive Urine Samples for Ureaplasma spp},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {285},
  doi = {10.3390/antibiotics15030285}
}
Kostenlos starten →